Published in Catheter Cardiovasc Interv on July 01, 2006
Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature. Clin Res Cardiol (2006) 1.07
Long-term outcomes of patients receiving drug-eluting stents. CMAJ (2008) 0.90
Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation. Indian Heart J (2014) 0.77
A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study). Indian Heart J (2013) 0.76
A chemical stability study of trimethylsilane plasma nanocoatings for coronary stents. J Biomater Sci Polym Ed (2016) 0.75
Preclinical evaluation of a novel abluminal surface coated sirolimus eluting stent with biodegradable polymer matrix. Cardiovasc Diagn Ther (2015) 0.75
A prospective study evaluating efficacy of polymer free Pronova XR stent in treatment of denovo coronary artery stenosis. Indian Heart J (2014) 0.75
Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry. BMJ Open (2016) 0.75
Intravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial. Int J Cardiovasc Imaging (2016) 0.75
The dawn of neurosurgery in pre-conquest Mesoamerican territories. Childs Nerv Syst (2017) 0.75
[Coronary stent thrombosis: what's new in 2011?]. Herz (2011) 0.75
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. N Engl J Med (2015) 3.81
Intracoronary ultrasound assessment late after the arterial switch operation for transposition of the great arteries. J Am Coll Cardiol (2005) 1.77
Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv (2011) 1.72
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES). J Am Coll Cardiol (2005) 1.67
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2003) 1.62
First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial. EuroIntervention (2014) 1.58
Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions. J Invasive Cardiol (2008) 1.50
Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: a serial intravascular ultrasound study. Catheter Cardiovasc Interv (2005) 1.43
Assessing the temporal course of neointimal hyperplasia formation after different generations of drug-eluting stents. JACC Cardiovasc Interv (2011) 1.42
Angiographic and intravascular ultrasound findings of the late catch-up phenomenon after intracoronary beta-radiation for the treatment of in-stent restenosis. J Invasive Cardiol (2005) 1.42
Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: a sub-study of the ABSORB Cohort B and the on-going ABSORB EXTEND Single Arm Study. Catheter Cardiovasc Interv (2011) 1.41
Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial. Catheter Cardiovasc Interv (2013) 1.40
Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial. Catheter Cardiovasc Interv (2013) 1.39
Novel guidewire-based stent delivery system: Examination by intravascular ultrasound. Catheter Cardiovasc Interv (2008) 1.39
The revascular active percutaneous interventional device for coronary total occlusions study. Catheter Cardiovasc Interv (2008) 1.38
Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold. EuroIntervention (2015) 1.38
First nine-month complete invasive assessment (angiography, IVUS, and OCT) of the novel NEVO sirolimus-eluting stent with biodegradable polymer. Catheter Cardiovasc Interv (2011) 1.37
Late outcome of sirolimus-eluting stents: comparison of multidetector computed tomography with quantitative coronary angiography and intravascular ultrasound. Arq Bras Cardiol (2006) 1.37
Bioresorbable scaffolds: rationale, current status, challenges, and future. Eur Heart J (2013) 1.22
New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv (2010) 1.14
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation (2003) 1.11
Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial. J Am Coll Cardiol (2012) 1.09
Organized thrombus mimicking spontaneous coronary artery dissection. JACC Cardiovasc Interv (2014) 1.07
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv (2013) 1.03
Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation (2005) 1.01
1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial. JACC Cardiovasc Interv (2009) 0.95
Images in cardiovascular medicine. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination. Circulation (2004) 0.92
Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions. Am J Cardiol (2006) 0.90
Transcatheter aortic valve replacement in elderly patients. J Geriatr Cardiol (2012) 0.90
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv (2013) 0.87
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions. Eur Heart J (2004) 0.84
Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system. JACC Cardiovasc Interv (2008) 0.84
Percutaneous aortic valve replacement for the treatment of aortic stenosis: early experience in Brazil. Arq Bras Cardiol (2009) 0.84
Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry. Catheter Cardiovasc Interv (2015) 0.83
Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry. J Interv Cardiol (2008) 0.83
Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late "catch-up" phenomenon after Cypher® sirolimus-eluting stent implantation. Int J Cardiovasc Imaging (2010) 0.83
EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions. EuroIntervention (2008) 0.82
Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound. Am J Cardiol (2003) 0.81
Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents. Am J Cardiol (2004) 0.81
Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. J Am Coll Cardiol (2011) 0.81
Preliminary results of the INSPIRE trial with the novel MGuard stent system containing a protection net to prevent distal embolization. Catheter Cardiovasc Interv (2010) 0.81
Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels. Am Heart J (2007) 0.81
Vessel remodeling and plaque distribution in side branch of complex coronary bifurcation lesions: a grayscale intravascular ultrasound study. Int J Cardiovasc Imaging (2013) 0.80
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. Circ Cardiovasc Interv (2010) 0.80
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. Am J Cardiol (2003) 0.80
Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy? Arq Bras Cardiol (2014) 0.80
Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial. Circulation (2004) 0.79
Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. Am J Cardiol (2007) 0.79
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions. Circ Cardiovasc Interv (2011) 0.78
First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial. EuroIntervention (2013) 0.78
Symetis ACURATE TF™ aortic bioprosthesis. EuroIntervention (2013) 0.78
Dedicated bifurcation analysis: dedicated devices. Int J Cardiovasc Imaging (2011) 0.78
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study. EuroIntervention (2010) 0.78
A novel mechanism explaining early lumen loss following balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol (2005) 0.78
Randomized comparison of distal and proximal cerebral protection during carotid artery stenting. JACC Cardiovasc Interv (2013) 0.78
[Guidelines for the indications of intracoronary ultrasonography in clinical practice]. Arq Bras Cardiol (2003) 0.77
Transcatheter bioprosthesis implantation for the treatment of aortic stenosis: three-year experience. Arq Bras Cardiol (2012) 0.77
Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis. Am J Cardiol (2005) 0.77
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES). EuroIntervention (2005) 0.77
Serial angiography and intravascular ultrasound: results of the SISC Registry (Stents In Small Coronaries). JACC Cardiovasc Interv (2010) 0.77
Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial. Catheter Cardiovasc Interv (2007) 0.77
One-year outcome of small-vessel disease treated with sirolimus-eluting stents: a subgroup analysis of the e-SELECT registry. J Interv Cardiol (2012) 0.77
Unilateral renal artery sympathetic denervation may reduce blood pressure in patients with resistant hypertension. J Clin Hypertens (Greenwich) (2013) 0.77
Renal sympathetic denervation and ventricular arrhythmias: a case of electrical storm with multiple renal arteries. EuroIntervention (2014) 0.76
Intravascular ultrasound observations of atherosclerotic lesion formation and restenosis in patients with diabetes mellitus. Int J Cardiovasc Intervent (1999) 0.76
Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography. Int J Cardiovasc Imaging (2013) 0.76
Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectiveness. Arq Bras Cardiol (2013) 0.75
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial. EuroIntervention (2016) 0.75
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions. EuroIntervention (2006) 0.75
Efficacy of reduced-dose sirolimus-eluting stents in the human coronary artery: serial IVUS analysis of neointimal hyperplasia and luminal dimension. Catheter Cardiovasc Interv (2007) 0.75
Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilation. Am J Cardiol (2004) 0.75
Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents. EuroIntervention (2012) 0.75
One-year clinical outcomes after sirolimus-eluting coronary stent implantation for acute myocardial infarction in the worldwide e-SELECT registry. J Interv Cardiol (2012) 0.75
Angiographic and intravascular ultrasound findings following implantation of the Endeavor zotarolimus-eluting stents in patients from the real-world clinical practice. EuroIntervention (2009) 0.75
Impact of the Occlusion Duration on the Performance of J-CTO Score in Predicting Failure of Percutaneous Coronary Intervention for Chronic Total Occlusion. J Invasive Cardiol (2017) 0.75
[Randomized intravascular ultrasound comparison between endoprostheses with and without amorphous silicon-carbide]. Arq Bras Cardiol (2004) 0.75
Long-term follow up of diabetic patients treated with sirolimus-eluting stents. An angiographic and three-dimensional intravascular ultrasound study. J Invasive Cardiol (2006) 0.75
Efficacy and feasibility of helixcision for debulking neointimal hyperplasia for in-stent restenosis. Catheter Cardiovasc Interv (2002) 0.75
Initial experience with the novel 6 Fr-compatible system for debulking de novo coronary arterial lesions. Catheter Cardiovasc Interv (2004) 0.75
Influence of balloon pressure inflation in patients undergoing primary coronary stent implantation during acute myocardial infarction. A quantitative coronary angiography analysis. Arq Bras Cardiol (2003) 0.75
[Rescue percutaneous coronary intervention after fibrinolysis]. Arq Bras Cardiol (2004) 0.75
Intravascular ultrasound analysis of small-vessel lesions treated with novel ultra-low profile, guidewire-based self-expanding stent system. J Invasive Cardiol (2008) 0.75
Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry. Int J Cardiol (2013) 0.75
Intravascular ultrasound comparison of small coronary lesions between novel guidewire-based sirolimus-eluting stents and conventional sirolimus-eluting stents. J Invasive Cardiol (2012) 0.75
Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study. J Invasive Cardiol (2008) 0.75
[Comparative assessment of the prognostic value of four biochemical markers of myocardial damage after percutaneous coronary stenting]. Arq Bras Cardiol (2004) 0.75
Are paclitaxel-eluting stents safe and effective in patients with acute coronary syndromes? Nat Clin Pract Cardiovasc Med (2005) 0.75
10-year follow-up of the first Cypher stent implanted in human: an invasive evaluation with angiography, intravascular ultrasound, and optical coherence tomography. JACC Cardiovasc Interv (2010) 0.75
Correlation between quantitative angiographic and intravascular ultrasound parameters in patients treated with sirolimus analogous-eluting stents. Int J Cardiovasc Imaging (2009) 0.75
One-year results of the INSPIRE trial with the novel MGuard stent: serial analysis with QCA and IVUS. Catheter Cardiovasc Interv (2011) 0.75